|
KIAA0753 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.51176999999558E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.550030E-04 |
| Normal-vs-Stage2 |
8.181800E-04 |
| Normal-vs-Stage3 |
2.14939999998442E-06 |
| Normal-vs-Stage4 |
1.93348999999454E-05 |
| Stage1-vs-Stage2 |
8.086200E-01 |
| Stage1-vs-Stage3 |
1.762570E-01 |
| Stage1-vs-Stage4 |
1.077980E-01 |
| Stage2-vs-Stage3 |
4.732400E-01 |
| Stage2-vs-Stage4 |
2.874000E-01 |
| Stage3-vs-Stage4 |
5.687400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.16160000005217E-06 |
| Normal-vs-AfricanAmerican |
2.104000E-02 |
| Normal-vs-Asian |
1.502120E-02 |
| Caucasian-vs-AfricanAmerican |
4.734000E-01 |
| Caucasian-vs-Asian |
1.419050E-01 |
| AfricanAmerican-vs-Asian |
7.358200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.819100E-04 |
| Normal-vs-Female |
3.24119999994821E-06 |
| Male-vs-Female |
3.179600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.47580000000336E-05 |
| Normal-vs-Age(41-60Yrs) |
1.68248999999898E-05 |
| Normal-vs-Age(61-80Yrs) |
1.52866999999501E-05 |
| Normal-vs-Age(81-100Yrs) |
1.029900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.872600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.955200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.617000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.126600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.055000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.950600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.08959999995029E-06 |
| Classical-VS-Follicular |
5.285600E-01 |
| Classical-VS-Other |
6.854000E-01 |
| Classical-VS-Normal |
1.972170E-04 |
| Tall-VS-Follicular |
1.421510E-03 |
| Tall-VS-Other |
1.473010E-01 |
| Tall-VS-Normal |
3.87959997460996E-10 |
| Follicular-VS-Other |
6.063600E-01 |
| Follicular-VS-Normal |
5.819100E-04 |
| Other-VS-Normal |
2.897800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.83630000000412E-05 |
| Normal-vs-N1 |
1.359970E-03 |
| N0-vs-N1 |
8.110000E-01 |
|
|
